SEVERE NECROTIZING CUTANEOUS LESIONS COMPLICATING TREATMENT WITH INTERFERON BETA-1B

被引：48

作者：

SHEREMATA, WA

TAYLOR, JR

ELGART, GW

机构：

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1995年 / 332卷 / 23期

关键词：

D O I：

10.1056/NEJM199506083322316

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1584 / 1584

页数：1

共 4 条

[1] CHRONIC SYSTEMIC HIGH-DOSE RECOMBINANT INTERFERON ALFA-2A REDUCES EXACERBATION RATE, MRI SIGNS OF DISEASE-ACTIVITY, AND LYMPHOCYTE INTERFERON-GAMMA PRODUCTION IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS [J].

DURELLI, L ;

BONGIOANNI, MR ;

CAVALLO, R ;

FERRERO, B ;

FERRI, R ;

FERRIO, MF ;

BRADAC, GB ;

RIVA, A ;

VAI, S ;

GEUNA, M ;

BERGAMINI, L ;

BERGAMASCO, B .

NEUROLOGY, 1994, 44 (03) :406-413

[2] SYSTEMIC ALPHA-INTERFERON THERAPY OF MULTIPLE-SCLEROSIS [J].

KNOBLER, RL ;

PANITCH, HS ;

BRAHENY, SL ;

SIPE, JC ;

RICE, GPA ;

HUDDLESTONE, JR ;

FRANCIS, GS ;

HOOPER, CJ ;

KAMINLEWIS, RM ;

JOHNSON, KP ;

OLDSTONE, MBA ;

MERIGAN, TC .

NEUROLOGY, 1984, 34 (10) :1273-1279

[3]

SHEREMATA WA, 1994, ANN NEUROL, V32, P327

[4]

The IFNB Multiple Sclerosis Study Group, 1993, NEUROLOGY, V43, P655

← 1 →